On the recordMarch 28, 2023
I disagree with CMS's coverage decision to tightly restrict coverage for an entire class of FDA-approved Alzheimer's drugs.
Source
congress.gov“I disagree with CMS's coverage decision to tightly restrict coverage for an entire class of FDA-approved Alzheimer's drugs.”
Barragan criticizes CMS for restricting coverage of approved Alzheimer's drugs.
Share
More from Nanette Barragán
I want to thank you for your leadership on this, and thank you for your leadership in keeping Americans covered.
Shipping plays a vital role in our economy, and at the Ports of Los Angeles and Long Beach, but it should not come at the expense of the health of our families. The Next Generation Shipping Act is about investing in cleaner technologies…
My district includes the Port of Los Angeles, the busiest port by container volume in the country.
It was under the prior administration, the Trump administration, that the EPA budget was effectively slashed, it was gutted.
Other voices in this conversation